Xeris Pharmaceuticals just received FDA clearance for the first-ever hypoglycemia glucagon rescue pen, akin to an EpiPen for diabetes.
| FDA OKs New Xeris Ready-To-Use Gvoke Glucagon | | Xeris Pharmaceuticals just received FDA clearance for the first-ever hypoglycemia glucagon rescue pen, akin to an EpiPen for diabetes. READ ON  | | | Type 1 Diabetes and Exercise: What You Need to Know | | | DiabetesMine explores the risks and benefits of exercise for those living with type 1 diabetes. READ ON | | | Type 2 Diabetes Blogger Seeks "Judgment-Free Space" | | | DiabetesMine interviews Mila Clarke Buckley from Texas, a type 2 diabetes Patient Voices Contest Winner, blogger and advocate against stigma. READ ON | | | Ask D'Mine: Can Declining Kidney Function Help Us Outlive Diabetes? | | | Our weekly diabetes advice column explores whether kidneys in older people with type 2 diabetes may produce less glucose, helping disease control. READ ON | |  We're on Twitter! Stay up to date on the latest type 1 diabetes news. |  Join us on Facebook Connect with 32,000 people who have tapped into our type 1 diabetes community. | |
No comments:
Post a Comment